IP Verse

Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters

Patent No. EP3744326 (titled "Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters") was filed by Janssen Pharmaceutica on Mar 30, 2016. The application was issued on Dec 6, 2023.

Patent Summary

A method for reinitiating treatment with a 3-month paliperidone palmitate extended-release injectable suspension in patients who have missed their scheduled doses. The method involves administering the medication at intervals of up to 9 months after the initial treatment period, with dosing windows of 4-9 months. This approach enables patients to maintain treatment efficacy while minimizing the risk of relapse due to nonadherence. The dosing regimen is achieved through precise administration of the medication using fine needles, ensuring optimal absorption and therapeutic effect.

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ADVANZ PHARMA SERVICES UKSep 6, 2024FUCHS PATENTANWALTE PARTNERSCHAFT MBB
APPLEYARD LEESSep 5, 2024APPLEYARD LEES
HOFFMANN EITLESep 5, 2024HOFFMANN EITLE
STADA ARZNEIMITTELSep 5, 2024HAMM & WITTKOPP
ELKINGTON AND FIFESep 4, 2024ELKINGTON AND FIFE
SANDOZSep 4, 2024MAIWALD
STRAWMANSep 4, 2024VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
ACCORD HEALTHCAREAug 28, 2024BRAND MURRAY FULLER
TEVA PHARMACEUTICALSAug 28, 2024D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3744326

JANSSEN PHARMACEUTICA
Application Number
EP20169861A
Filing Date
Mar 30, 2016
Status
Granted And Under Opposition
Nov 3, 2023
Publication Date
Dec 6, 2023
External Links
Slate, Register , Google Patents